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INTRODUCTION
Persistent viral genomes are observed after a number of acute viral infections in humans, including respiratory syncytial virus, measles, and Ebola [1] [2] [3] . A number of host factors, including impaired or altered cytokine production and progressive loss of immunological functions support the maintenance of persistent infections 4 . However, the processes and cellular mechanisms determining the onset of viral persistence after acute viral infections remain unknown.
The innate immune response is the first active host barrier to virus replication and is essential to control and clear the infection. The antiviral innate response is initiated upon recognition of viral molecular patterns by cellular sensor molecules. Activation of these sensor pathways leads to the expression of genes with pro-inflammatory, antiviral, and pro-apoptotic activities that control virus growth and spread. During infections with important human pathogens including the respiratory syncytial virus (RSV), parainfluenza virus, and measles virus, the antiviral response is triggered by replication defective copy-back viral genomes (DVGs) that accumulate during viral replication [5] [6] [7] [8] . DVGs potently stimulate intracellular RIG-Ilike receptors (RLRs) that signal through the mitochondrial antiviral-signaling (MAVS) protein to stimulate the expression of genes that control virus replication and spread, and direct clearance of infected cells 9, 10 .
Paradoxically, DVGs also promote the establishment of persistent RSV, parainfluenza, and measles virus infections in tissue culture [11] [12] [13] [14] and are proposed to be responsible for establishing persistent Ebola virus infections in humans 1 . This pro-persistence activity of DVGs has been related to the continuous competition for the viral polymerase between full-length genomes and DVGs, resulting in alternating cycles of replication of full-length and defective genomes [15] [16] [17] . However, this mechanism can't explain the survival of virus-infected cells in the presence of strong pro-apoptotic and antiviral molecules, including type I IFNs and TNFα, that are induced in response to sensing of DVGs 10 .
In order to better understand the host-virus interactions driving the establishment of persistent infections of otherwise acute viruses, we developed technology that allowed us to investigate at a single cell level the mechanisms behind the different activities of DVGs in infected cells. Using fluorescent in situ hybridization targeting ribonucleic acid molecules (RNA FISH) to distinguish DVGs from standard viral genomes during infection, we reveal that DVGs from two different viruses accumulate only in a subpopulation of infected cells, and that these cells survive the infection longer than cells enriched in full-length virus, leading to the establishment of persistent infections. Moreover, the survival of DVG-high cells is dependent on MAVS signaling, and we identify TNFα produced in response to MAVS signaling as pivotal in determining cell fate. We show that while cells harboring full-length viral genomes die from virus induced TNF-mediated apoptosis, cells enriched in DVGs regulate the expression and activity of a TNFR2/TRAF1 pro-survival program that protects them from TNF-induced apoptosis. This study reveals a mechanism by which distinct viral genomic products determine cell fate upon infection by taking advantage of the dual functions of TNFα to perpetuate both virus and host.
RESULTS

DVGs dominate in a subpopulation of infected cells.
To better understand the impact of DVGs during infection, we established a RNA FISH assay that allowed us to differentiate full-length genomes from the murine parainfluenza virus Sendai (FL-gSeV) from SeV DVGs at a single cell level. As copy-back DVGs are generated from the 5'end of the viral genome and thus have a high sequence homology with the FL-gSeV 18, 19 , we utilized a two-color probing strategy to distinguish DVGs from FL genomes within infected cells ( Figure 1A ). To detect replicating virus, a set of probes labeled with Quasar-570 (pseudo-colored red) was designed against the 5' end of the positive sense viral RNA and a different set of probes labeled with Quasar-670 (pseudo-colored green) was designed against the 3' end of the positive sense SeV genome, which covers the viral genomic sequence shared with DVGs. As a result of this design, DVGs are only bound by Quasar-670-labeled probes (denoted 'DVG'), while FL-gSeV are bound by a combination of Quasar-570 and Quasar-670-labeled probes (denoted 'FL-gSeV' and appearing as orange in the images) ( Figure 1A) . To test the specificity of the labeling, we infected cells with SeV lacking DVGs (LD) alone or complemented with purified defective particles containing DVGs (pDPs). Cells infected with SeV LD demonstrated a strong FL-gSeV signal and no DVG signal, while addition of pDPs resulted in detection of cells with strong positive DVG signal ( Figure 1B ). Further, Quasar-670labeled DVG probes detected in vitro transcribed DVG RNA transfected into cells and did not cross-react with the synthetic RNA poly I:C or with host GAPDH mRNA ( Figure 1C and S1A and B), confirming their specificity.
Analysis of various epithelial cell lines infected with SeV containing high levels of
DVGs (HD) showed an unexpected heterogeneous distribution of Quasar-570 and 670 signals at 24 and 48 h post infection, indicating differential accumulation of DVGs and FL-gSeV among infected cells ( Figure 1D and Figure S1C ). The phenotype was recapitulated upon hybridization with probes that targeted the negative sense FL-gSeV ( Figure S1D ). In addition, heterogeneous distribution of FL-gSeV and DVGs was also observed upon natural accumulation of DVGs in vivo during SeV infection ( Figure 1E ). Further, after sorting cells negative for both Quasar-570 and 670 staining (Non-detected: ND, gated in blue), DVG-high (gated in green), and FL-gSeV high (FL-high, gated in orange), we confirmed their differential content of FL-gSeV and DVG DVG-high cells accumulated quickly upon infection, plateaued, and decreased at later time points, while accumulation of FL-high cells followed behind, reminiscent of the waves of accumulation of defective interfering particles and FL-genomes used to explain the interfering activity of DVGs ( Figure 1K) 20, 21 . As expected based on their characterization of primary immunostimulatory molecules during SeV infection 9, 10, 22 , early accumulation of DVG-high cells was associated with expression of high levels of IFNB1 mRNA ( Figure 1L ). In contrast, the kinetics of SeV NP mRNA expression followed that of the FL-high populations, but not that of the DVG-high population. Taken together, these data demonstrate a heterogeneous physical and functional distribution of DVGs and FL-gSeV during SeV infection.
DVG-high cells are less prone to apoptosis than FL-high cells, facilitating the development of persistently infected cultures.
To examine how DVG accumulation in a subpopulation of cells impact the establishment of persistently infected cultures, we infected susceptible LLC-MK2 cells with SeV LD or HD and monitored the presence of infected cells overtime. Cultures infected with SeV LD died 8 days after infection (Figures 2A and B ), while cultures infected with SeV HD recovered from a cell death crisis and were able to be passaged for at least 17 days (Figures 2A, 2B and S2A).
Remarkably, a substantially higher proportion of DVG-high cells survived by day 5 post SeV HD infection compared to FL-high cells (Figure 2A ), and by day 17 post infection, approximately 34% of the total survivors were DVG-high compared to 5.47% FL-high ( Figure   2C ). Importantly, infectious virus was detected in the supernatant of survivor cells at day 17 post SeV HD infection, confirming the ability of DVGs to support a persistent productive infection ( Figure 2D ). The predominance of DVG-high cell in the surviving cell population together with our inability to generate persistently infected LLC-MK2 cultures during infection with SeV LD virus stocks, suggest that DVGs confer resistance to SeV-induced cell death. In support, the percentage of dead cells measured by viability staining was significantly higher in FL-high cells than DVG-high cells at 24 and 48 h post infection in both LLC-MK2 and A549 cells ( Figure 2E and F, and data not shown). Notably, the percentage of dead cells among the DVG-high subpopulation did not significantly increase over time, whereas the percentage of dead cells among FL-high cells increased at 48 h post infection matching the spike on total cell death in the culture ( Figure 2G ). To assess whether DVGs protect cells from apoptosis, a major mechanism of cell death during SeV infection 23, 24 , we stained the cultures for the hallmark apoptotic molecules To investigate whether the differential accumulation of DVGs and FL-genomes among infected cells and the associated phenotype applied to other paramyxoviruses, we infected A549 cells with RSV with a high content of DVGs (HD) and analyzed the cultures by RNA FISH using specific probes designed following the same strategy as described for SeV. As with SeV 
DVG-high cells express a unique transcriptional profile enriched in genes encoding prosurvival proteins.
To characterize the mechanism protecting DVG-high cells from apoptosis, we identified candidate pathways by transcriptionally profiling sorted FISH-stained ND, FL-high, and DVGhigh cells at 24 h post SeV HD infection using RNA-Seq. A detailed description of the pipeline for these studies is presented in Figure S4A Figure S4D ).
RNA-Seq analysis identified 1800 differentially expressed genes among the FL-high, DVG-high, and ND populations (≥ 2 fold change in expression with ≤ 1% false discovery rate).
Increased expression of a number of genes in the different cell populations was validated by RT-qPCR ( Figure S4E ). Hierarchical clustering revealed at least three distinct clusters of coregulated genes. Clusters 1, 2, and 3 represent genes with relatively higher expression in ND cells, DVG-high cells, or FL-high cells, respectively ( Figure 4A ). Gene Ontology analysis of cluster 1 (upregulated in ND cells) was highly enriched in genes involved in cell cycle checkpoints, complement and antigen presentation, and the IFN signaling pathway ( Figure 4B ). These signatures include TNF-related genes with anti-apoptotic functions, such as the TNF receptor 2 (TNFR2 or TNFRSF1B), TNF receptor associated factor 1 (TRAF1), and the TNF alpha induced protein 3 (TNFAIP3, also known as A20) 25 , molecules involved in regulation of NF-κB activity (for example, NFKBIA and NFKBIE) 26 , and a number of genes involved in apoptosis regulation, including the baculoviral IAP repeat containing 3 (BIRC3, also know as c-IAP2) 27,28 ( Figure 4D ). In addition, the DVG-high population was enriched in genes involved in the induction of IFNs and expression of cytokines and chemokines, consistent with a welldescribed role of DVGs in initiating antiviral immunity 9, 10, 29 . Collectively, these studies show that host cells enriched in DVGs actively engage both an anti-viral and a pro-survival program.
DVG-high cells are protected from a MAVS/TNF-dependent apoptosis.
To determine if accumulation of DVG-high cells and death of FL-high cells depended on the antiviral response induced by DVGs 9,10 , we analyzed infections of cells lacking the critical adaptor protein MAVS (MAVS KO) or lacking the type I IFN receptor (IFNAR1 KO). In this setting, differential accumulation of DVG-high and FL-high cells remained unchanged in MAVS or IFNAR1 KO cells, suggesting that the heterogeneous accumulation of DVGs is independent of the engagement of the antiviral response ( Figure 5A ). In addition, the percentage of apoptotic cells in both DVG-high and FL-high populations, remained similar in WT and IFNAR1 KO cells The lower level of apoptosis in SeV HD infected MAVS KO cells compared to controls was not due to reduced viral replication, as MAVS KO cells showed increased viral replication ( Figure   S5A ).
Transcriptional profiling suggested that TNFα-related pathways are implicated in defining the cell fate during SeV infection. Due to the well-documented dual roles of TNFα in both inducing cell death and conferring survival 30 , we next investigated whether TNFα signaling orchestrates the differential pro-and anti-apoptotic responses of FL-high and DVG-high cells.
As expected, SeV infection induced high levels of TNFα protein and mRNA in a MAVSdependent but IFNAR1-independent manner ( Figure 5D and Figure MAVS signaling dictates the survival of DVG-high cells.
We next investigated how DVG-high cells become less prone to TNFα-mediated apoptosis compared to FL-high cells within the same infected culture. Based on RNA-Seq data showing upregulation of several genes in the TNFR2 signaling pathway in DVG-high cells,
including TNFR2 itself (TNFRSF1B) and TRAF1, we hypothesized that the TNFR2 pathway is responsible for the protection of DVG-high cells from virus-triggered apoptosis. To test this hypothesis, we neutralized either the primary TNF receptor, TNFR1, or TNFR2 in SeV HD Thus, the TNFR2 pathway, which is upregulated in DVG-high cells in a MAVS-dependent manner, protects this population from SeV induced TNFα mediated apoptosis. Together, these data demonstrate that engagement of MAVS/TNFR2 axis by DVGs allow a sub-population of infected cells to survive TNFα mediated apoptosis, which is potentially exploited by the virus to achieve long-term persistence.
DISCUSSION
In this study we demonstrate that while cells respond to DVGs inducing the expression of anti-viral molecules that restrict virus production, they also engage a pro-survival TNFR2/TRAF1-dependent mechanism that promotes viral persistence. Our data support a model providing an alternative explanation for the long standing observation of waves of DVGs and FL-viral genome dominance in infected cultures 16, 31 . Our evidence of distinct cellular populations based on viral genomic content and the resulting differential susceptibility to cell death, reveal an underappreciated cellular level of regulation of persistent viral infections.
Our data demonstrate that, during virus infection, cells with a high content of FL-gSeV are susceptible to TNFα but not type-I IFN mediated apoptosis. The apparent lack of proapoptotic activity of IFN over FL-high cells is likely caused by the strong IFN signaling antagonistic activity of paramyxovirus proteins 32 . TNFα is a pro-inflammatory cytokine that can be induced by viral infection and plays important roles in the control of virus dissemination 33, 34 .
Expression of TNFα has been reported in many paramyxovirus infections, including RSV, SeV, Newcastle disease viruses, and parainfluenza virus 5 (also known as simian virus 5) 35, 36 .
Importantly, TNFα expression is stimulated by DVGs in both SeV and RSV infections 6, 29 . In addition, purified defective viral particles from SeV can cause selective apoptosis of transformed cells by activating the TNF-related apoptosis-inducing ligand (TRAIL) both in vitro and in vivo 37 . Together, this evidence indicates that DVGs can drive TNF-mediated apoptosis of virus infected cells through a mechanism distinct from that leading to cell death after LD infections, likely caused by virus induced cell stress.
Unexpectedly, a robust pro-survival TNF signature was found in DVG-high cells. Overall, here we describe an intricate mechanism in which virus and host come to a balance to establish a symbiotic interaction. The virus benefits from this mechanism because it allows extended survival of virus-infected cells, establishing a persistent infection. This relationship is founded in the dual role of TNF in targeting highly infected cells (FL-high) for apoptosis while protecting cells with active MAVS signaling (DVG-high) from cell death. This mechanism fundamentally changes our understanding of the relationship between antiviral responses and viral persistence and reveals potential therapeutic targets to eliminate persistent viral reservoirs.
METHODS
Ethics statement.
Studies in mice were carried out in strict accordance with the recommendation in the Guide for 
Viruses.
Sendai virus strain 52, Sendai virus strain Cantell HD and LD stocks (SeV HD, high DVG particle content; SeV LD, low DVG particle content) were prepared in embryonated chicken eggs as described previously 9, 10 . SeV Cantell HD stock had consistently an infectious: total particle ratio of 5,00-15,000. RSV-LD (stock of RSV derived from strain A2, ATCC, #VR-1540 with a low content of DVGs) and RSV-HD (stock of RSV derived from strain A2, ATCC, #VR-1540 with a high content of DVGs) were prepared and characterized as described previously 6, 43 .
For SeV titration, LLC-MK2 cells were infected with triplicate serial 1:10 dilutions of the virus stock or 1:10 dilution of supernatant from infected cell cultures in the presence of 2 mg/ml of trypsin to determine the medium tissue culture infectious dose (TCID 50 ). After 72 h of incubation at 37°C, supernatant from each well was tested by hemagglutination of chicken RBCs for the presence of virus particles at the end point dilution as describe in 9 . For virus infections in vitro, cells were incubated with virus at a multiplicity of infection (MOI) of 1.5 TCID 50 /cell unless otherwise indicated in the figure.
RNA extraction and RT-qPCR.
Total RNA was extracted using TRIzol (Invitrogen) according to the manufacturer's specifications and 1-2 µg of RNA was reverse transcribed using the High Capacity RNA-to cDNA kit (Applied Biosystems). cDNA was amplified with specific primers in the presence of SYBR green (Applied Biosystem). qPCR reactions were performed in triplicate using an Applied Biosystem ViiA7 Real-time Lightcycler. For the primers used, see Table S1 . For FL-gSeV and SeV DVGs detection 1-2 µg of isolated total RNA was reverse transcribed with specific primers for DVG (5'GGTGAGGAATCTATACGTTATAC3') and FL-gSeV (5'-TGTTCTTACTAGGACAAG-3') using Superscript III without RNaseH activity to avoid selfpriming. Recombinant RNase H (Invitrogen) was later added to the reverse transcribed samples.
cDNA was amplified with viral product specific qPCR primers listed in Table S1 in the presence of SYBR green (Applied Biosystem). Copy numbers were normalized to the housekeeping gene GAPDH. RSV DVGs were detected by regular PCR method. Detailed PCR conditions for RSV DVGs and genome detection can be found in previous publications of the lab 6 .
Preparation of in vitro transcribed DVG RNA.
To generate in vitro transcribed SeV DVG RNA, a plasmid expressing SeV-DVG (pSL1180-DVG546 described previously in Xu et al., 2015) , was linearized and in vitro transcribed using the MEGAscript T7 kit (Ambion) in the presence of RNase inhibitors (Invitrogen). The resulting products were then treated with DNase and then precipitated with LiCl (both included in the MEGAscript T7 kit). All in vitro transcribed DVG RNA had optical density at 260 nm (OD260)/ OD280 ratios between 2.00 and 2.25, and the OD260/ OD230 ratios were between 2.20 and 2.60.
Single-molecule RNA fluorescence in situ hybridization (RNA FISH) and immunofluorescence staining (IF).
RNA fluorescence in situ hybridization (RNA FISH) was performed according to published protocols with some modifications 44 
RNA FISH-FLOW and FACS-sorting.
The same procedure was applied for RNA FISH-FLOW cytometry (RNA FISH-FLOW) as was used for the slides based RNA FISH described previously excepted that cells were kept in suspension throughout the staining process. Briefly, monolayer cells were trypsinized, resuspended in 1% FBS in PBS, then fixed and permeabilized in 100% methanol for at least 15 min on ice. Hybridization was performed in100 µl hybridization buffer in presence of 1. 
RNA-Seq of FISH FACS-sorted cells.
Four sub-populations of cells (ND, FL-high, DVG-high and INT) were sorted from infected cultures after RNA FISH. RNA-Seq was performed in two replicates where the RNA of each replicate was a pool from 3 independent FISH-FACS sortings (6 independent sortings in total).
RNA samples from FISH-FACS-sorted cells were prepared as follows: RNA extracted using TRIzol reagent was re-purified using the PicoPure TM RNA isolation kit (Thermo Fisher Scientific). Quality of the RNA was assessed by using the RNA Pico 6000 module on an Agilent Tapestation 2100 (Agilent Technologies). A schematic diagram for the FISH-FACS-sorting pipeline coupled with RNA-Seq is provided in Fig. S5A . Briefly, total cDNA libraries were prepared starting from 75 ng of extracted raw RNA using the Illumina TruSeq Stranded Total RNA LT kit with Ribo-Zero Gold, according to the manufacturer's instructions. Samples were run on Illumina NextSeq 500 to generate 75 bp, single-end reads, resulting in 21-53 million reads/sample with an average Q30 score ≥ 96.8%. All data were processed and analyzed by R programming language (v 3.2.2, R core team, 2016) and the RStudio interface (v 0.99.489), as described previously 45 . For host transcriptome analysis, raw fastq files were mapped to the human transcriptome (cDNA; Ensembl release 86) using Kallisto with 60 bootstraps per sample 45, 46 . Annotation and summarization of transcripts to genes was carried out in R, using the TxImport package 47 . Differentially expressed genes (≥ 2 fold and ≤ 1% false discovery rate) were identified by linear modeling and Bayesian statistics using the VOOM function in Limma package 48, 49 . Gene Ontology (GO) was performed using the Database for Annotation, Visualization and Integration of Data (DAVID) 50, 51 . Gene Set Enrichment Analysis (GSEA) was analyzed through Molecular Signatures Database (MSigDB) using the C2 canonical pathway collection 52 . For genome alignment, seq reads from the duplication of each population were combined and aligned to the full length genome of SeV strain Cantell using Subread aligner in the RSubread package 53 . This allowed us to extract only the viral reads from the total. Resulting BAM files were visualized as a track on the full length SeV Cantell genome using the Genious software (version 7.1.9, Biomatters develop team) for further alignment to the full length SeV Cantell genome to obtain the different coverages of viral reads from each of the four populations.
TNFR2 extracellular staining for flow cytometry
Extracellular staining of TNFR2 on A549 cells for flow cytometry was performed as follows: cells harvested in 1% FBS PBS were stained with anti-human-TNFR2 antibodies (2 µg/10 6 cells, R&D system) in 1% FBS PBS on ice for 40 min, washed three times by 1%FBS PBS and then subjected to secondary antibody staining using goat anti-donkey Alexa Fluor 488 antibody (Invitrogen;1:1000 diluted in 1%FBS PBS ) on ice for 30 min. Stained cells was acquired in a BD LSRFortessa TM and analyzed using the FlowJo (Tree Star) software.
TNFα neutralization and supplementation of infected cells.
For TNFα neutralization experiments, 70-80 % confluent A549 cells were pre-treated with neutralizing antibody against control IgG or TNFα, TNFR1 and TNFR2 (R&D system) at 2 µg/ml/antibody or with IgG control antibody (R&D system) 
